dr. ravandi on targeting cd33 in relapsed/refractory aml
Published 5 years ago • 93 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
1:22
dual-targeting cd33/cd123 nanobody® t cell engager in relapsed aml
-
1:40
findings for the bite antibody amg 330 in relapsed/refractory aml
-
5:07
relapsed vs. refractory data for flt3 inhibitors in aml
-
1:43
cd33-tim3 dual car t-cells enhance specificity of aml treatment
-
8:13
naval daver, ash 2019: venetoclax in combination with idasanutlin in relapsed or refractory aml
-
3:45
imgn632: a novel cd123 adc for r/r aml and bpdcn
-
2:23
amg 673: novel half-life extended anti-cd33/cd3 bite in r/r aml
-
1:28
quizartinib provides clinical benefit in r/r flt3-itd aml
-
3:04
ff-10101-01: a novel flt3 inhibitor for r/r aml
-
4:09
quantum-r: quizartinib looks promising for flt3-itd mutated aml
-
7:39
examination of vitals
-
13:10
new husband receives single level disc replacement
-
3:03
quantum-first: flt3-itd-specific mrd to assess benefits of quizartinib in flt3-itd aml
-
6:35
treating erectile dysfunction - a novel option
-
3:02
pinnacle³ auto-planning
-
3:40
lead avr the neglected lead - md/dnb general medicine
-
0:29
diode laser 1470 nm spider vein removal machine triangel tr-b
-
2:13
6 months after 3-level cervical disc replacement by enande. adjacent segment disease or syndrome